Personalized therapy for lung cancer.

Abstract excerpt

The past decade has seen an enormous advancement in the therapy for lung cancer, predominantly seen in adenocarcinoma, ranging from the introduction of histology-based drugs to the discovery of targetable mutations. These events have led to a personalized therapeutic approach with the delivery of drugs that target specific oncogenic pathways active in a given tumor with the intent of acquiring the best response...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Risk Assessment
• Share to Survival Analysis
• Share to Molecular Targeted Therapy